D&P Biotech Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 4

D&P Biotech General Information

Description

Developer of molecular diagnostics DNA biomarkers designed to provide customized medicine. The company's molecular diagnostics DNA biomarkers are effective and helps to detect and manage lung cancer, enabling patients to begin the treatment more quickly and result in a higher likelihood of a successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Number 518, Building C, 7, Beopwon- ro 11-gil, Songpa-gu
  • Munjeong-dong, Munjeong Hyundai Knowledge Industry Center
  • Seoul, 05836
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

D&P Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Apr-2017 Completed Generating Revenue
1. Early Stage VC 01-Jul-2010 Completed Generating Revenue
To view D&P Biotech’s complete valuation and funding history, request access »

D&P Biotech Executive Team (1)

Name Title Board Seat Contact Info
Lee Myung-hoon Chief Executive Officer
To view D&P Biotech’s complete executive team members history, request access »

D&P Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hanwha Investment Corporate Venture Capital Minority 000 0000 000000 0
KT investment Venture Capital Minority 000 0000 000000 0
Korea-Seoul Life Science Fund Venture Capital Minority 000 0000 000000 0
Korea Technology Finance Government Minority 000 0000 000000 0
To view D&P Biotech’s complete investors history, request access »